Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Multitasking plasmonic nanobubbles kill some cells, modify others

04.12.2012
Rice University discovery could simplify and improve difficult processes used to treat diseases, including cancer
Researchers at Rice University have found a way to kill some diseased cells and treat others in the same sample at the same time. The process activated by a pulse of laser light leaves neighboring healthy cells untouched.

The unique use for tunable plasmonic nanobubbles developed in the Rice lab of Dmitri Lapotko shows promise to replace several difficult processes now used to treat cancer patients, among others, with a fast, simple, multifunctional procedure.

The research is the focus of a paper published online this week by the American Chemical Society journal ACS Nano and was carried out at Rice by biochemist Lapotko, research scientist and lead author Ekaterina Lukianova-Hleb and undergraduate student Martin Mutonga, with assistance from the Center for Cell and Gene Therapy at Baylor College of Medicine (BCM), Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center.

Plasmonic nanobubbles that are 10,000 times smaller than a human hair cause tiny explosions. The bubbles form around plasmonic gold nanoparticles that heat up when excited by an outside energy source – in this case, a short laser pulse – and vaporize a thin layer of liquid near the particle’s surface. The vapor bubble quickly expands and collapses. Lapotko and his colleagues had already found that plasmonic nanobubbles kill cancer cells by literally exploding them without damage to healthy neighbors, a process that showed much higher precision and selectivity compared with those mediated by gold nanoparticles alone, he said.

The new project takes that remarkable ability a few steps further. A series of experiments proved a single laser pulse creates large plasmonic nanobubbles around hollow gold nanoshells, and these large nanobubbles selectively destroy unwanted cells. The same laser pulse creates smaller nanobubbles around solid gold nanospheres that punch a tiny, temporary pore in the wall of a cell and create an inbound nanojet that rapidly “injects” drugs or genes into the other cells.

In their experiments, Lapotko and his team placed 60-nanometer-wide hollow nanoshells in model cancer cells and stained them red. In a separate batch, they put 60-nanometer-wide nanospheres into the same type of cells and stained them blue.

After suspending the cells together in a green fluorescent dye, they fired a single wide laser pulse at the combined sample, washed the green stain out and checked the cells under a microscope. The red cells with the hollow shells were blasted apart by large plasmonic nanobubbles. The blue cells were intact, but green-stained liquid from outside had been pulled into the cells where smaller plasmonic nanobubbles around the solid spheres temporarily pried open the walls.

Because all of this happens in a fraction of a second, as many as 10 billion cells per minute could be selectively processed in a flow-through system like that under development at Rice, said Lapotko, a faculty fellow in biochemistry and cell biology and in physics and astronomy. That has potential to advance cell and gene therapy and bone marrow transplantation, he said.

Most disease-fighting and gene therapies require “ex vivo” – outside the body – processing of human cell grafts to eliminate unwanted (like cancerous) cells and to genetically modify other cells to increase their therapeutic efficiency, Lapotko said. “Current cell processing is often slow, expensive and labor intensive and suffers from high cell losses and poor selectivity. Ideally both elimination and transfection (the introduction of materials into cells) should be highly efficient, selective, fast and safe.”

Plasmonic nanobubble technology promises “a method of doing multiple things to a cell population at the same time,” said Malcolm Brenner, a professor of medicine and of pediatrics at BCM and director of BCM’s Center for Cell and Gene Therapy, who collaborates with the Rice team. “For example, if I want to put something into a stem cell to make it turn into another type of cell, and at the same time kill surrounding cells that have the potential to do harm when they go back into a patient — or into another patient — these very tunable plasmonic nanobubbles have the potential to do that.”

The long-term objective of a collaborative effort among Rice, BCM, Texas Children’s Hospital and MD Anderson is to improve the outcome for patients with diseases whose treatment requires ex vivo cell processing, Lapotko said.

Lapotko plans to build a prototype of the technology with an eye toward testing with human cells in the near future. “We’d like for this to be a universal platform for cell and gene therapy and for stem cell transplantation,” he said.

The work was supported by the National Institutes of Health.

Read the abstract at http://pubs.acs.org/doi/abs/10.1021/nn3045243

This news release can be found online at news.rice.edu.

Follow Rice News and Media Relations via Twitter @RiceUNews

Related Materials:
The Plasmonic Nanobubble Lab at Rice: http://pnblab.blogs.rice.edu

David Ruth | EurekAlert!
Further information:
http://www.rice.edu
http://news.rice.edu/2012/12/03/multitasking-plasmonic-nanobubbles-kill-some-cells-modify-others-2/

More articles from Life Sciences:

nachricht Rice study decodes genetic circuitry for bacterial spore formation
24.05.2016 | Rice University

nachricht How Neural Circuits Implement Natural Vision
24.05.2016 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Mit atomarer Präzision: Technologien für die übernächste Chipgeneration

Im Projekt »Beyond EUV« entwickeln die Fraunhofer-Institute für Lasertechnik ILT in Aachen und für angewandte Optik und Feinmechanik IOF in Jena wesentliche Technologien zur Fertigung einer neuen Generation von Mikrochips mit EUV-Strahlung bei 6,7 nm. Die Strukturen sind dann kaum noch dicker als einzelne Atome und ermöglichen besonders hoch integrierte Schaltkreise zum Beispiel für Wearables oder gedankengesteuerte Prothesen.

Gordon Moore formulierte 1965 das später nach ihm benannte Gesetz, wonach sich alle ein bis zwei Jahre die Komplexität integrierter Schaltungen verdoppelt. Er...

Im Focus: Ein negatives Enzym liefert positive Resultate

In den letzten zwanzig Jahren hat die Chemie viele wichtige Instrumente und Verfahren für die Biologie hervorgebracht. Heute können wir Proteine herstellen, die in der Natur bisher nicht vorkommen. Es lassen sich Bilder von Ausschnitten lebender Zellen aufnehmen und sogar einzelne Zellen in lebendigen Tieren beobachten. Diese Woche haben zwei Forschungsgruppen der Universitäten Basel und Genf, die beide dem Nationalen Forschungsschwerpunkt Molecular Systems Engineering angehören, im Forschungsmagazin «ACS Central Science» präsentiert, wie man ein nicht-natürliches Protein designt, das völlig neue Fähigkeiten aufweist.

Proteine sind die Arbeitspferde jeder Zelle. Sie bestehen aus Aminosäurebausteinen, die als Kette verbunden sind, welche sich zu funktionalen Maschinen...

Im Focus: Atomic precision: technologies for the next-but-one generation of microchips

In the Beyond EUV project, the Fraunhofer Institutes for Laser Technology ILT in Aachen and for Applied Optics and Precision Engineering IOF in Jena are developing key technologies for the manufacture of a new generation of microchips using EUV radiation at a wavelength of 6.7 nm. The resulting structures are barely thicker than single atoms, and they make it possible to produce extremely integrated circuits for such items as wearables or mind-controlled prosthetic limbs.

In 1965 Gordon Moore formulated the law that came to be named after him, which states that the complexity of integrated circuits doubles every one to two...

Im Focus: FS POSEIDON startet zur 500. Expedition

Das am GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel beheimatete Forschungsschiff POSEIDON startet diese Woche zu seiner 500. Expedition. Während der Jubiläumsfahrt untersuchen und kartieren Meeresgeologen des MARUM – Zentrum für Marine Umweltwissenschaften der Universität Bremen den Kontinentalhang vor der südfranzösischen Hafenstadt Nizza. Ziel der Arbeiten ist es, die Gefahr von Hangrutschungen und letztendlich auch Tsunamis besser abschätzen zu können.

Am kommenden Mittwoch heißt es wieder einmal „Leinen los“ für die POSEIDON. Von Catania auf Sizilien aus nimmt das 60 Meter lange Forschungsschiff Kurs auf die...

Im Focus: Spinströme: Riesengroß und ultraschnell

Mit einer neuen Methode der TU Wien lassen sich extrem starke Spinströme herstellen. Sie sind wichtig für die Spintronik, die unsere herkömmliche Elektronik ablösen könnte.

In unseren Computerchips wird Information in Form von elektrischer Ladung übertragen. Elektronen oder andere Ladungsträger werden von einem Ort zum anderen...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

„Zukunftsforum Assekuranz“ 2016 am 21. und 22. Juni 2016 in Köln

24.05.2016 | Veranstaltungen

Chemische Biologie im Fokus

24.05.2016 | Veranstaltungen

Innovationen für Laserexperten und Anwender - Universität Stuttgart bei Stuttgarter Lasertagen 2016

24.05.2016 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Neuartige Terahertz-Quelle: kompakt und kostensparend

24.05.2016 | Physik Astronomie

Baufritz-Musterhaus „NaturDesign“ übt sich in Understatement: Gesundes Wohnen mit Stil

24.05.2016 | Architektur Bauwesen

„Zukunftsforum Assekuranz“ 2016 am 21. und 22. Juni 2016 in Köln

24.05.2016 | Veranstaltungsnachrichten